Wanbury Ltd. Financials

NSE BSE

15:48 Jul 18

Wanbury Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

274.15

+2.90 (+1.07%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

274.15

+2.90 (+1.07%)
15:48 Jul 18

Quality

54/100
Medium Financial Strength

Valuation

40/100
Mid Valuation

Technical

58/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	392.52	511.19	499.65	575.65	599.51
Operating Expenses +	374.51	475.87	476.48	505.65	523.2
Raw Material	224.35	325.07	273.46	306.52	292.96
Increase Decrease in Cost	-7.2	-24.79	29.13	-3.89	1.51
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	64.15	74.81	81	86.92	104.24
Miscellaneous Expenses	114.51	141.06	124.85	150.7	154.65
Operating Profit	18.01	35.32	23.17	70	76.31
Other Income	2.4	1.51	0.91	2.99	3.49
Depreciation	9.75	11.45	12.38	13.03	13.31
Interest	23.07	20.61	21.39	29.18	36.95
Profit before tax and exceptio..	-12.41	4.76	-9.69	30.78	29.55
Exceptional Items	0	76.37	-0.59	25.56	0
PBT	-12.41	81.13	-10.29	56.34	29.55
Provision for Taxation	0.2	-0.35	0.11	0.38	-0.98
Net Profit	-12.61	81.47	-10.4	55.96	30.53
NET Profit after MI	-12.61	81.47	-10.4	55.96	30.53
EPS	-5.04	25.29	-3.18	17.1	8.98
Operating Profit Margin (%)	4.59	6.91	4.64	12.16	12.73
Net Profit Margin (%)	-3.21	15.94	-2.08	9.72	5.09

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	39.60	39.80	39.80	39.80	39.80
FII	1.60	1.60	0.80	1.00	0.20
MF	0.00	0.00	0.00	0.00	0.00
Others	0.00	-0.10	0.00	0.00	0.00

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: